The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evolution of tisagenlecleucel use for the treatment of pediatric and young adult relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL): Center for International Blood & Marrow Transplant Research (CIBMTR) registry results.
 
Rayne H. Rouce
Honoraria - Novartis
Consulting or Advisory Role - Pfizer
Research Funding - Tessa Therapeutics (Inst)
 
Susanne H.C. Baumeister
Employment - Takeda (I)
Stock and Other Ownership Interests - AstraZeneca (I); Takeda (I)
 
Kevin J. Curran
Consulting or Advisory Role - Atara Biotherapeutics; Celgene; Cellectis; Novartis
Research Funding - Celgene (Inst); Cellectis (Inst); Novartis (Inst)
Other Relationship - Atara Biotherapeutics
 
Vanessa A. Fabrizio
Consulting or Advisory Role - Adaptimmune
 
Erin M. Hall
Honoraria - Vida Diagnostics (I)
Consulting or Advisory Role - Polarean (I)
Speakers' Bureau - Boehringer Ingelheim (I)
 
Emily M. Hsieh
No Relationships to Disclose
 
Nicole A. Karras
No Relationships to Disclose
 
Amy K. Keating
No Relationships to Disclose
 
Amy Moskop
No Relationships to Disclose
 
Marcelo C. Pasquini
Honoraria - Celgene; Gilead Sciences
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Medigene (Inst); Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst); Kite/Gilead (Inst); Novartis (Inst)
 
Christine L. Phillips
Consulting or Advisory Role - Novartis
 
Michael A. Pulsipher
Consulting or Advisory Role - Equillium; Medexus Pharmaceuticals; Mesoblast; Novartis
Speakers' Bureau - Miltenyi Biomedicine; Novartis
Research Funding - Adaptive Biotechnologies; Miltenyi Biomedicine (Inst)
 
Marja Nuortti
Employment - Novartis
 
Jennifer Willert
Employment - Novartis
 
Roberto Ramos
Employment - Novartis
 
Samuel John
No Relationships to Disclose
 
Stephan A. Grupp
Consulting or Advisory Role - Adaptimmune; Allogene Therapeutics; Cabaletta Bio; Cellectis; Cellular Biomedicine Group; GlaxoSmithKline; Humanigen; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Juno Therapeutics; Novartis; Roche; TCR2 Therapeutics; Vertex
Research Funding - Kite, a Gilead Company (Inst); Novartis (Inst); SERVIER (Inst); Vertex (Inst)